- Country: Republic of Korea
- Official Title: Associated Professor
- Department: Internal Medicine
- Institute: Seoul National University College of Medicine
- E-Mail: jaminbyun@snu.ac.kr
Speech Title
Current Myeloma Treatment in Korea
Multiple myeloma (MM) treatment is highly dependent on health-care resource distribution and thus vary greatly across the globe. This talk will focus on (1) how we deal with newly diagnosed transplant eligible MM patients in Korea; (2) options for relapsed refractory MM patients, and creative yet cost-effective combinations to close the gap while avoiding economic/regulatory constraints; and (3) Korean experience with newer therapeutic agents, specifically bispecific antibodies.